Dec 16, 2024

Dr. Shika Pappoe, CMO and COO of Carna Health is working to identify and treat chronic kidney disease earlier through screening tests. This is a breakthrough for a disease that often shows no symptoms until the damage is irreversible. Using technology and AI-powered risk prediction models to improve early detection and intervention for CKD can help slow or even halt the progression of the disease. In recent pilot programs in Bermuda and Cameroon, Carna Health found high rates of CKD and is working to connect those patients with the necessary care.  

Shika explains, "Chronic kidney disease is a condition that has been growing over the years. We know that diabetes and hypertension are leading causes, and currently, CKD is the 10th leading cause of death globally. And by 2040, it's estimated that it will be the fifth cause of death. Carna is working on finding ways to identify kidney disease early so that we can slow progression and optimize the outcomes of patients around the world."

"We are seeing globally increasing rates of, again, diabetes and hypertension, the number one and two causes globally. Interestingly, communicable diseases have often been the priority in low- and middle-income countries. Still, we're seeing the rise of noncommunicable diseases such as CKD. I should say one of the other causes of this increasing epidemic is the environmental stressors, particularly heat. So. we see a lot of individuals who are working or living in very hot climates who are developing recurrent episodes of acute kidney injury, which ultimately leads to CKD. So, we have numerous causes for the increasing epidemic of CKD around the globe."

#CarnaHealth #ChronicKidneyDisease #CKD #EarlyDetectionCKD

Carna.Health

Listen to the podcast here